who is eligible for glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Medicare Bridge Program Explained: GLP-1
Description
doi: 10.1016/j.apsb.2021.12.016
doi: 10.3390/ijms23073451
Diabetes 65(1):3443
The decision to continue or discontinue Zepbound should weigh the benefits of weight loss against any mental health concerns, with patient safety and well-being as the primary consideration
This includes clear instructions on how to start at a low dose to minimize the chance of allodynia and GI issues
This is why the Allurion Programme places great importance on readjusting your mindset towards food, behaviour change and building better habits for long-term weight management
